Lanean...
Antisense Therapie Neurologischer Erkrankungen
There are few disease-modifying therapeutics for neurodegenerative diseases. Antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy, Duchenne muscular dystrophy, and transthyretin amyloidosis predict a robust future for ASOs in medicine. Perhaps the most significant advantage to AS...
Gorde:
| Argitaratua izan da: | Nervenarzt |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6730669/ https://ncbi.nlm.nih.gov/pubmed/31165208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00115-019-0724-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|